E-LIB Suche - Ergebnisse für: Rihawi, K.

1

162TiP Phase II study of consolidation treatment with holmi..:

Borelli, B. ; Bargellini, I. ; Carullo, M....
Annals of Oncology. 35 (2024) - p. S72-S73 , 2024

Link: https://doi.org/10.1016/..

2

MA18.09 Carboplatin, Etoposide, Bevacizumab, and Atezolizum..:

Lamberti, G. ; Rihawi, K. ; Riccardi, F....
Journal of Thoracic Oncology. 18 (2023) 11 - p. S168-S169 , 2023

Link: https://doi.org/10.1016/..

3

EP14.01-006 CeLEBrATE: Phase II trial of CarbopLatin, Etopo..:

Andrini, E. ; Lamberti, G. ; Mazzoni, F....
Journal of Thoracic Oncology. 17 (2022) 9 - p. S528-S529 , 2022

Link: https://doi.org/10.1016/..

4

Encorafenib plus cetuximab with or without binimetinib in p..:

Boccaccino, A. ; Borelli, B. ; Intini, R....
ESMO Open. 7 (2022) 3 - p. 100506 , 2022

Link: https://doi.org/10.1016/..

5

Complications of hyperglycaemia with PI3K–AKT–mTOR inhibito..:

Geuna, E ; Roda, D ; Rafii, S...
British Journal of Cancer. 113 (2015) 11 - p. 1541-1547 , 2015

Link: https://doi.org/10.1038/..

6

2027 KRAS status and risk of venous thromboembolic events i..:

Rihawi, K. ; Fontanella, C. ; Rossini, D....
European Journal of Cancer. 51 (2015) - p. S337 , 2015

Link: https://doi.org/10.1016/..

7

1238 Major factors predicting multiple accesses and hospita..:

Garattini, S.K. ; Fontanella, C. ; Rihawi, K....
European Journal of Cancer. 51 (2015) - p. S186 , 2015

Link: https://doi.org/10.1016/..

8

2153 Analysis ofthe molecular profile of brain metastases f..:

Casagrande, M. ; Rihawi, K. ; Fontanella, C....
European Journal of Cancer. 51 (2015) - p. S384-S385 , 2015

Link: https://doi.org/10.1016/..

9

Health Information Technology in Oncology Practice: A Liter..:

Fasola, G. ; Macerelli, M. ; Follador, A....
Cancer Informatics. 13 (2014) - p. CIN.S12417 , 2014

Link: https://doi.org/10.4137/..

10

Encorafenib plus cetuximab with or without binimetinib in p..:

Boccaccino, A ; Borelli, B ; Intini, R...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9271503/. , 2022

Link: http://www.ncbi.nlm.nih...

11

Tumor-associated macrophages and inflammatory microenvironm..:

Rihawi K ; Ricci A. D ; Rizzo A...
info:eu-repo/semantics/altIdentifier/wos/WOS:000644303700001. , 2021

Link: http://hdl.handle.net/11..

12

Novel HER2-directed treatments in advanced gastric carcinom..:

Ricci A. D ; Rizzo A ; Llimpe F. L. R...
info:eu-repo/semantics/altIdentifier/pmid/33916206. , 2021

Link: https://hdl.handle.net/1..

13

Two first-in-human studies of xentuzumab, a humanised insul..:

de Bono, J ; Lin, C-C ; Chen, L-T...
https://eprints.whiterose.ac.uk/179681/1/Two%20first-in-human%20studies%20of%20xentuzumab,%20a%20humanised%20insulin-like%20growth%20factor%20%28IGF%29-neutralising%20antibody,%20in%20patients%20wi.pdf. , 2020

Link: https://eprints.whiteros..

14

Two first-in-human studies of xentuzumab, a humanised insul..:

de Bono, J ; Lin, C-C ; Chen, L-T...
British journal of cancer, 2020, 122 (9), pp. 1324 - 1332. , 2020

Link: https://repository.icr.a..

15

Higher Risk of Infections with PI3K-AKT-mTOR Pathway Inhibi..:

Rafii, S ; Roda, D ; Geuna, E...
Clinical cancer research : an official journal of the American Association for Cancer Research, 2015, 21 (8), pp. 1869 - 1876. , 2020

Link: https://repository.icr.a..